ADORA1 and the top 4 significant genes, including MYBPH, FAM178B, CHI3L1 and METTL7B were selected as the hub genes for genetic variation, interrelationship, cancer pathway and drug susceptibility analysis. This evidence concerns the gene CHI3L1 and cancer.